LSNE Contract Manufacturing Revenue and Competitors

Claim your profile

Bedford, NH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LSNE Contract Manufacturing's estimated annual revenue is currently $57.8M per year.(i)
  • LSNE Contract Manufacturing's estimated revenue per employee is $155,000

Employee Data

  • LSNE Contract Manufacturing has 373 Employees.(i)
  • LSNE Contract Manufacturing grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.5M145-2%N/AN/A
#2
$19.2M124-13%N/AN/A
#3
$6.4M41N/AN/AN/A
#4
$5.4M35N/A$1.7MN/A
#5
$7.6M4944%N/AN/A
#6
$23.7M15319%$45.5MN/A
#7
$24M1558%N/AN/A
#8
$12.7M825%$179.8MN/A
#9
$57.8M3736%N/AN/A
#10
$11.5M744%N/AN/A

LSNE Contract Manufacturing is a CMO with a proven regulatory history specializing in a wide range of services including process development, fill/finish and lyophilization. LSNE has been providing cGMP services to the pharmaceutical, biotechnology and medical device industries since 1997. Through the thoughtful integration of three processing facilities, qualified staffing and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted material for clinical through commercial use. With on-site development services, LSNE can partner with clients to optimize their current formulation and lyophilization cycle or develop a cycle from scratch and perform the necessary feasibility work. Once development activities are complete, LSNE can formulate, fill, lyophilize and package finished products. LSNE's highly skilled personnel and automated equipment, work together to provide consistent, quality material. LSNE offers both the flexible approach commonly required with preclinical projects, as well as the cGMP framework necessary for late stage clinical and commercial manufacturing. Specializing in the production of high-quality small to medium size batches, LSNE is perfectly suited for orphan indications or products with modest annual volumes. LSNE's experienced development, operations, quality and project management teams evaluate project objectives and recommend an optimal path forward to achieve easier regulatory submissions and a faster time to market. LSNE's flexibility and responsiveness allow them to make their client's batch a top priority so they can meet their client's timelines and exceed their expectations. For more information, contact LSNE Contract Manufacturing at (603) 668-5763 or visit www.lyophilization.com.

keywords:Biotechnology,Healthcare

N/A

Total Funding

373

Number of Employees

$57.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LSNE Contract Manufacturing News

2020-08-27 - LSNE-León Receives Approval From AEMPS To Manufacture Biotechnology Based Therapeutic Products

BEDFORD, N.H., Aug. 27, 2020 /PRNewswire/ -- LSNE Contract Manufacturing, a leading contract development and manufacturing organization, is pleased to announce that the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the manufacturing of clinical stage biotechnology based ...

2021-01-14 - LSNE Expands Vial Fill Finish and Lyophilization Operations with New Automated Fill Line

BEDFORD, N.H., Jan. 14, 2021 /PRNewswire/ -- LSNE Contract Manufacturing, a leading contract development and manufacturing organization (CDMO) expands vial filling and lyophilization capacity with the addition of a new automated aseptic fill line. The new aseptic fill line will be housed in an ...

17-Jun-19 - LSNE Completes Acquisition of Sterile Injectables ...

LSNE Completes Acquisition of Sterile Injectables Manufacturing Facility ... (LSNE), a leading contract development and manufacturing ...

19-Jun-19 - LSNE acquires sterile injectables manufacturing facility

Lyophilization Services of New England, a Bedford-based contract manufacturer, has acquired a sterile injectables manufacturing facility in ...

25-May-17 - LSNE tapped for drug substance manufacturing, fill-finish ...

LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3822%N/A
#2
$131M3883%N/A
#3
$141.8M42032%N/A
#4
$115.5M4200%N/A
#5
$65.1M42011%N/A